Latest News
A new study on a gene called VPS13C adds to growing evidence that lysosomal dysfunction may be one mechanism through which Parkinson’s disease arises.
- March 11, 2025
This #TraineeTuesday, we introduce Sydney Cason, PhD, a Postdoctoral Associate in the De Camilli Lab! She was recently awarded the Life Sciences Research Foundation (LSRF) Postdoctoral Fellowship, a prestigious private award that provides three years of salary and research allowance.
- November 21, 2024
Yale School of Medicine teams have received three grants totaling $18 million from Aligning Science Across Parkinson’s (ASAP), a coordinated research initiative devoted to accelerating the pace of discovery and informing the path to a cure for Parkinson’s disease (PD) research.
- October 14, 2024
The new Yale center is the first to focus on developing precision medicine for Parkinson’s disease.
- August 01, 2024
Neuroscience and Cell Biology postdoctoral fellow Sydney Cason, PhD, is one of the 21 Life Science Research Foundation 2024 Awardees.
- May 03, 2024
The Kavli Institute for Neuroscience is pleased to announce the recipients of the 2024 Kavli Postdoctoral Fellowship: Drs. Hongyan Hao, Kevin Chen, and Dhananjay Bhaskar.
- February 06, 2024
This #TraineeTuesday, we are highlighting Chase Amos, a graduate student in the De Camilli Lab! He recently published a report in Contact on the connection between the two proteins VPS13A and XK in red blood cell precursors, and a paper in Molecular Biology of the Cell.
- August 15, 2023
A team of Yale neuroscience researchers sheds light on the early steps of a transport event.
- April 27, 2023
Pietro de Camilli, MD, John Klingenstein Professor of Neuroscience and professor of Cell Biology, was awarded the van Deenen Medal.
- July 14, 2022Source: YaleNews
In two new papers, scientists provide insight into the function of a protein called VPS13C, one of the molecular suspects that underlie Parkinson’s, a disease marked by uncontrollable movements including tremors, stiffness, and loss of balance.